Reducing fear responses in phobia patients using brain activity techniques
Official title: Unconscious Reduction of Fear Through Decoded Neuro-Reinforcement
Run by University of California, Los Angeles · NCT06420557 · Data updated 2026-11-12
This study is testing a new way to help people with phobias, like fear of spiders or snakes, by using brain activity techniques to reduce their fear without them having to face their fears directly.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | September 9, 2024 |
| Main results expected | March 30, 2027 |
| Study ends | March 30, 2027 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT06420557 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with specific phobias of animals who have normal or corrected vision and hearing.
✕Probably not a fit
Patients with neurological disorders, severe psychological conditions, or those unable to participate in assessments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This application investigates a novel method of neuro-reinforcement that utilizes decoded fMRI activity to unconsciously reduce fear responses in individuals with specific phobias, such as fear of spiders or snakes. Unlike traditional exposure therapy, which requires conscious confrontation with feared stimuli, this method aims to minimize distress by bypassing conscious awareness. The study employs a double-blind placebo-controlled design to ensure rigorous evaluation of the treatment's efficacy. The primary goals include confirming the method's engagement with the amygdala and assessing its impact on behavioral outcomes related to fear responses.
Why it matters
Potential benefit: If successful, this approach could provide a less distressing and more effective treatment option for individuals suffering from phobias.
How similar studies have gone: While traditional exposure therapies have been widely studied, this specific approach using unconscious neuro-reinforcement is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individual has normal or corrected to normal vision 2. Individual has normal or corrected to normal hearing 3. Individual is competent to understand informed consent 4. Individual must meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria for specific phobias, animal subtype Exclusion Criteria: 1. Individual is unable to fill in consent form correctly 2. Individual is unable to respond adequately to screening questions 3. Individual is unable to maintain focus or to sit during assessment 4. Individual has history of: neurological disease or defect (e.g., stroke, traumatic brain injury, schizophrenia or other psychological disorders, or seizures) Individual has vision problems (including cataracts, amblyopia, or glaucoma) Individual presents with: Obsessive Compulsive Disorder, Substance Use Disorder, Bipolar Disorder, Psychosis, neurologic diagnoses or unstable serious medical conditions 5. Participant receives an elevated score on the PHQ-9 6. Individual does not present with more than one object of specific phobia 7. Individual can touch the phobic object category during the pre-treatment Behavioral Approach Test without presenting significant distress 8. Individual is currently prescribed psychotropic medication
Where it's running
-
University of California, Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Michelle G Craske, PhD — University of California, Los Angeles
- Study coordinator: Gabriel J Fiol, B.A.
- Email: gfiol@psych.ucla.edu
- Phone: 7252228834
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Team-delivered exposure-based CBT for children and teens with anxiety and OCD
This test tries three ways of delivering team-based exposure-focused CBT—in-person, by telehealth, or a flexible mix—to see which works best for kids and teens (ages 5–18) with anxiety or OCD.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Protein supplements with or without spices to protect muscle for people on GLP-1 weight loss meds
This pilot test checks whether daily whey protein, with or without mixed spices, helps preserve muscle mass and strength in adults using GLP-1 weight-loss medicines.
-
Diet Quality Matters: A Nutrition Education Program for Los Angeles Food Rx Participants
A community-based program will test whether tailored nutrition education and cooking sessions can help low-income adults in LA improve diet quality and reduce cardiometabolic risk.
-
Diet quality in older adults and how two dietary tools compare
This study tests two diet-quality questionnaires in adults 60 and older who use LA Food Rx produce programs to see which better reflects their eating and BMI.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.